Drugs of abuse in urine
Código del producto
PT-DU-FULL-W
Esquema de ensayos de aptitud
Matriz
Sector industrial
Formato del producto
3 x 15ml lyophilized human urine. Full participants will be able to report for the screening only analytes using immunoassay type techniques and individual analytes by chromatography type techniques. Approximately 210 individual analytes are available and are managed by your PORTAL online screening profile.
Acreditación
ISO/IEC 17043
Descripción general de las muestras del EA y las fechas de distribución:
Información del producto
Información de los analitos
Nombre del analito
Datos
Unidades
Acreditación
(-)-11-Nor-9-carboxy-delta9-THC
-
µg/L
(±)-Methadone
-
µg/L
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
-
µg/L
6-Acetylmorphine
-
µg/L
Amfetamine
-
μg/L
Amfetamines screen
-
μg/L
Barbiturates Screen
-
μg/L
Benzodiazepines screen
-
μg/L
Benzoylecgonine
-
μg/L
Buprenorphine and Metabolite Screen
-
μg/L
Buprenorphine or Metabolites
-
μg/L
Cannabinoid Screen
-
μg/L
Cocaine
-
μg/L
Cocaine and Metabolite Screen
-
μg/L
Codeine
-
μg/L
Delta-9-THC-COOH
-
μg/L
Dihydrocodeine
-
μg/L
EDDP Screen
-
μg/L
Hydrocodone
-
μg/L
Hydromorphone
-
μg/L
LSD and Metabolite Screen
-
μg/L
LSD or metabolites
-
μg/L
MDMA/MDA/MDEA
-
μg/L
Methadone Screen
-
μg/L
Methyl-amfetamine
-
μg/L
Morphine (total)
-
μg/L
Opiates screen
-
μg/L
Other amfetamine
-
μg/L
Oxycodone
-
μg/L
Oxymorphone
-
μg/L
Phencyclidine (PCP)
-
µg/L
Phencyclidine Screen
-
μg/L
Propoxyphene and Metabolite Screen
-
μg/L
Propoxyphene or metabolites
-
μg/L
Specific barbiturate
-
μg/L
Specific benzodiazepine
-
μg/L
Full membership = individual analytes by chromatography type techniques and screening only analytes using immunoassay type techniques. For Clinical and EWDTS thresholds, please see the DAU Scheme Description.
Para obtener detalles sobre la especificación técnica completa del esquema, consulte la Descripción del esquema.